O'Reilly Automotive Inc. Common Stock vs GeneDx Holdings Corp — how do they compare? O'Reilly Automotive Inc. Common Stock trades at $86.16 (market cap $69.58B), while GeneDx Holdings Corp trades at $69.62 (market cap $2.02B). The key difference: O'Reilly Automotive Inc. Common Stock is far larger — about 34.4× GeneDx Holdings Corp's market cap, and GeneDx Holdings Corp is more actively traded (734,640 versus 4,819,072). Which is the better fit depends on your goals.
| ORLY | WGS | |
|---|---|---|
Market Cap | $69.58B | $2.02B |
Volume | 4,819,072 | 734,640 |
Sector | Consumer Cyclical | Health |
52-Week High | $103.05 | $167.51 |
52-Week Low | $82.73 | $34.51 |
Enterprise Value | $78.90B | $2.05B |
Typical Hold Time | — | 19 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GeneDx Holdings Corp. (WGS) trades at $68.53, down 4.18% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a net loss of $21.02 million for 2025, though Q2 2026 earnings beat expectations. Revenue growth is positive, but profitability remains a challenge with negative margins. Analyst consensus is strongly bullish with a $81.00 price target, supported by recent product launches and institutional interest.
The outlook hinges on execution toward profitability amid high cash burn. Investment opportunity lies in the genomic testing market expansion and analyst optimism, but risks include sustained losses, competitive pressure, and reliance on financing. The stock's trajectory will depend on achieving projected margin improvements and revenue scalability.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
O'Reilly Automotive sells automotive aftermarket parts, tools, supplies, equipment, and accessories. It serves both professional service providers and do-it-yourself customers through its store network.
Read more on ORLY →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →